发明名称 Broad spectrum beta-lactamase inhibitors
摘要 Broad spectrum beta-lactamase inhibitors. Certain inhibitors also exhibit potent antibiotic activity in addition to beta-lactamase inhibition. Compounds of the invention are designed such that on cleavage of the beta-lactam ring reactive moieties are generated which can inactivate beta-lactamase. Also provided are methods of making beta-lactamase inhibitors and beta-lactam antibiotics exhibiting such inhibition. Additionally provided are pharmaceutical compositions for treatment or prevention of bacterial infections and methods of treatment of such infections.
申请公布号 US9453032(B2) 申请公布日期 2016.09.27
申请号 US201414491806 申请日期 2014.09.19
申请人 GLADIUS PHARMACEUTICALS CORPORATION 发明人 Sutton Larry;Yu Sophia
分类号 C07D501/22;C07D501/24;C07D501/60;A01N43/90;A61K31/00 主分类号 C07D501/22
代理机构 Lathrop & Gage LLP 代理人 Lathrop & Gage LLP
主权项 1. A compound of formula I: or a pharmacologically acceptable salt thereof, wherein: R is an acylamino group or an optionally substituted benzyl-NH— group; R1 and R2 are independently selected from hydrogen, halogen, a C1-C6 alkyl group, a C1-C6 alkoxy group and a —S—C1-C6-alkyl group; n is an integer ranging from 1-5; —Z— is present or absent and represents —O—(CH2)x-, —C—(CH2)x-, —NR′—(CH2)x-, —SO—(CH2)x-, or —SO2—(CH2)x-, where x is 0 or 1 and R′ is hydrogen or a C1-C6 alkyl group, when —Z— is present, y is 1 and when it is absent, y is 2; Y is O—C+ or OR3, where R3 is hydrogen, or an optionally substituted alkyl or aryl group and C+ is a pharmacologically acceptable cation; R4 is hydrogen, a C1-C6 alkyl group, or OR′, where R′ is hydrogen or a C1-C6 alkyl group; R5 is hydrogen, or a C1-C6 alkyl group; and M represents a chemical species which is in the cis or trans position with respect to R1, and which is selected from the group consisting of P, B, BZ, D, E, and F as follows: where: W is O or C(R″) and each R″ for W groups is independently selected from the group consisting of hydrogen, halogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group and a 6-10-member-ring heterocyclic aromatic group, wherein each of said groups is optionally substituted; and R6 and R7 are independently selected from hydrogen, halogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, a 6-10-member-ring heterocyclic aromatic group, a —COR″ group, a —COOR″ group, and a —CON(R″)2 group, wherein each R″ for R6 and R7 groups is independently selected from the group consisting of hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group and a 6-10-member-ring heterocyclic aromatic group, wherein each of said groups is optionally substituted; where: Z2 is O, NR11 or S, where R11 is selected from the group consisting of hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, and a C2-C6 alkynyl group, wherein each group is optionally substituted; each R8 is independently selected from hydrogen, halogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, 6-10-member-ring heterocyclic aromatic group, a C1-C6 alkoxy group, a —S—C1-C6-alkyl group, a —CO—R′ croup, a —CO2R′ croup, a —CO—N(R′)2 group; a —N(R′)2 group, a —NR′—CO—R′ group, and a —NR′CO2—R′ group, wherein each R′ for R8 groups is independently selected from hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group and a 6-10-member-ring heterocyclic aromatic group, wherein each of said groups is optionally substituted; and each R9 is independently selected from hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group and a 6-10-member-ring heterocyclic aromatic group, wherein each of said groups is optionally substituted; each R10 is independently selected from the group consisting of a —CH2—X group, hydrogen, halogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, 6-10-member-ring heterocyclic aromatic group, a C1-C6 alkoxy group, a —S—C1-C6-alkyl group, a —CO—R′ group, a —CO2R′ group, a —CO—N(R′)2 group; a —N(R′)2 group, a —NR′—CO—R′ group, and a —NR′—CO2—R′ group, wherein each R′ for R10 groups is independently selected from hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, and a 6-10-member-ring heterocyclic aromatic group, wherein each of said groups is optionally substituted; R12 is selected from the group consisting of X, hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, a 6-10-member-ring heterocyclic aromatic group, a C1-C6 alkoxy group, a —S—C1-C6-alkyl group, a —CO—R′ group, a —CO2R′ group, a —CO—N(R′)2 group; a —N(R′)2 group, a —NR′—CO—R′ group, and a —NR′—CO2—R′ group, wherein each R′ for R12 groups is independently selected from hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, and a 6-10-member-ring heterocyclic aromatic group, wherein each of said groups is optionally substituted; R13 and R14 are independently selected from the group consisting of X, hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, a 6-10-member-ring heterocyclic aromatic group, a C1-C6 alkoxy group, a —S—C1-C6-alkyl group, a —CO—R′ group, a —CO2R′ group, a —CO—N(R′)2 group; a —N(R′)2 group, a —NR′—CO—R′ group, and a —NR′—CO2—R′ group, wherein each R′ for R13 and R14 groups is independently selected from hydrogen, a C1-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C7-C19 aralkyl group, a 3-7-member-ring cyclic hydrocarbon group, a 3-7-member-ring heterocyclic group, a C6-C10 aromatic group, and a 6-10-member-ring heterocyclic aromatic group, wherein each of said groups is optionally substituted; wherein optional substitution includes substitution with one or more groups selected from a C1-C3 alkyl group, a C6-C12 aryl group, a C1-C3 haloalkyl group, I, Cl, Br, F, —CN, —OH, a C1-C3 alkoxy group, a —O-aryl group, a —O-benzyl group, a -phenoxy group, —SH, a —S—C1-C3-alkyl group, a —S-phenyl group, a —S-benzyl group, —NH2, and a —N(R16)2 group, where each R16 is a C1-C3 alkyl group, a benzyl group or a phenyl group; wherein X is a leaving group; wherein the compound contains one R2 and one M group; and wherein in structures B and Bz at least one R10 is a —CH2—X group, in structure E at least one R10 is a —CH2—X group, or R12 is X and in structure F one of R13 or R14 is X.
地址 Montreal, Quebec CA